[Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
D000818:Animals; D001011:Aorta; D001775:Blood Circulation / Q000187:drug effects*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D003864:Depression, Chemical; D004285:Dogs; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006333:Heart Failure / Q000188:drug therapy; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D066298:In Vitro Techniques; D009206:Myocardium / Q000378:metabolism; D005996:Nitroglycerin / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects; D012039:Regional Blood Flow / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013268:Stimulation, Chemical; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000009:adverse effects / Q000494:pharmacology*
D014665:Vasodilator Agents; D005996:Nitroglycerin
Physiologie der Coronardurchblutung als Grundlage für die Beurteilung von Coronardilatatoren.